Wayne Lewis, 71, a local member of the Wagga Wagga Prostate Cancer Support Group, doesn't want men to be put off being tested for prostate cancer ...
A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...
Docetaxel rechallenge significantly improved survival compared with cabazitaxel in certain men with metastatic ...
A trial evaluated the short-term oncologic efficacy of cooled focal therapy ablation using the ProFocal device in men with localized, intermediate-risk prostate cancer.
Black men have one of the highest rates of prostate cancer. In fact, 1 in 6 will develop the disease in their lifetimes. And we also have twice the risk of dying from prostate cancer compared to White ...
Australia: Researchers have found in a systematic review and meta-analysis that focal laser ablation offers oncological ...
A medication commonly used to treat overactive bladder significantly reduced hot flashes in men receiving hormone therapy for ...
In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite ...
A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across ...
Lt. Col. Ronald “RJ” Caras, a urologist at Madigan Army Medical Center, has been named the American Urological Association’s ...
New research exposes the molecular switches that let some cancers shapeshift and reveals how they might finally be stopped. Certain cancers are extremely difficult to treat, and carcinomas are among ...
It has been more than ten years since a group of cancer patients agreed to allow samples from their prostate glands to be used for research. Here in the laboratory, the samples are stored frozen in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results